Beatriz Serrano is a medical doctor specialised in preventive medicine and public health.
She received her medical degree the University of Valladolid (1998-2004) followed by a Master of Public Heath from the University Pompeu Fabra (2005-2006) and a Master in Research Methodology in Health Sciences from the Autonomous University of Barcelona (2005-2011), and she received her specialist training in preventive medicine and public health at the Hospital Clínic of Barcelona (2005-2009).
Since 2011, she has worked at the Catalan Institute of Oncology and in collaboration with the Information Centre on HPV and Cancer (HPV Information Centre), a worldwide project that aims to compile updated data and statistics on HPV and HPV-related cancers. She is also involved in several international projects aimed to describe the role of HPV infection in HPV-related cancers (i.e. cervix, vulva, vagina, penile, anal mucosae and head and neck cancers).
- Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015 Jun 26. pii: S0959-8049(15)00491-8. doi: 10.1016/j.ejca.2015.06.001. [Epub ahead of print]
- Serrano B, Alemany L, Ruiz PA, Tous S, Lima MA, Bruni L, Jain A, Clifford GM, Qiao YL, Weiss T, Bosch FX, de Sanjosé S. Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China). Cancer Epidemiol. 2014 Dec;38(6):748-56.
- Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, Bosch FX, de Sanjosé S. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer. 2012 Dec 29;7(1):38.
- de Sanjosé S, Serrano B, Castellsagué X, Brotons M, Muñoz J, Bruni L, Bosch FX. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report. Vaccine. 2012 Nov 20;30Suppl 4:D1-83.